Key facts
- This page summarizes Robert E. Landry's Form 4 filing for REGENERON PHARMACEUTICALS, INC. (REGN).
- 28 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 11 Apr 2022, 18:01.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Tax liability
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Options Exercise
Tax liability
Options Exercise
Tax liability
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Options Exercise
Additional SEC filing notes
Footnote F1
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Footnote F2
Represents volume-weighted average price of sales of 44 shares of Company stock on April 8, 2022 at prices ranging from $733.28 to $733.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 8, 2022 at each separate price.
Footnote F3
Represents volume-weighted average price of sales of 43 shares of Company stock on April 8, 2022 at prices ranging from $735.06 to $735.23. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 8, 2022 at each separate price.
Footnote F4
Represents volume-weighted average price of sales of 32 shares of Company stock on April 8, 2022 at prices ranging from $743.48 to $743.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 8, 2022 at each separate price.
Footnote F5
Represents volume-weighted average price of sales of 74 shares of Company stock on April 11, 2022 at prices ranging from $729.63 to $729.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
Footnote F6
Represents volume-weighted average price of sales of 37 shares of Company stock on April 11, 2022 at prices ranging from $731.57 to $731.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
Footnote F7
Represents volume-weighted average price of sales of 22 shares of Company stock on April 11, 2022 at prices ranging from $732.00 to $732.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
Footnote F8
Represents volume-weighted average price of sales of 1,226 shares of Company stock on April 11, 2022 at prices ranging from $733.40 to $733.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
Footnote F9
Represents volume-weighted average price of sales of 75 shares of Company stock on April 11, 2022 at prices ranging from $734.08 to $734.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
Footnote F10
Represents volume-weighted average price of sales of 149 shares of Company stock on April 11, 2022 at prices ranging from $735.02 to $735.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
Footnote F11
Represents volume-weighted average price of sales of 189 shares of Company stock on April 11, 2022 at prices ranging from $736.40 to $736.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
Footnote F12
The stock option award vests in four equal annual installments, commencing one year after the date of grant.